Assignment Upon Termination. In the event that SUBLICENSEE in its sole discretion decides to market one or more LICENSED PRODUCTs or LICENSED PROCESS in any country, then SUBLICENSEE shall exert reasonable efforts to have such LICENSED PRODUCT or LICENSED PROCESS cleared for marketing by the responsible government agencies of that country requiring such clearance. Should SUBLICENSEE terminate this Agreement, SUBLICENSEE agrees, if permitted by applicable law, to assign its full right, title, and interest in and to such market clearance application, including all data relating thereto, to TI at no cost to TI, without prejudice to any sub-sublicensee of SUBLICENSEE.
Appears in 2 contracts
Sources: Exclusive Sublicense Agreement, Exclusive Sublicense Agreement (ImmunoCellular Therapeutics, Ltd.)